China

Baozun Bets Big on Gap in China: Will 2025 Be Their Year?

Baozun Inc. broke its three-year profit drought with a 7.7% rise in Q4 revenue and plans to open 40 new Gap stores in China by 2025, signaling transformation. The company shifted focus from e-commerce software services to brand management, highlighted by acquiring

21 March 2025

Artificial intelligence·Automotive·Autonomous Vehicles·China·Intel·News·Reviews·Technology·Tesla

Tesla Paves the Road to Autonomy in China with Free Full Self-Driving Trial

Tesla is offering a complimentary Full Self-Driving (FSD) trial in China from March 17 to April 16 to enhance its market presence. FSD technology, powered by generative AI, faces unique challenges in China due to strict data regulations. To address data limitations,

17 March 2025

China·Healthcare·Market Trends·News·Reviews

China’s Thermometer Market Heats Up: Trends and Future in Focus

The China thermometer market is rapidly expanding, valued at $283.5 million in 2023 with a projected 15% CAGR growth through 2030. Traditional mercury thermometers are being replaced by advanced digital models due to increased health awareness and digital health monitoring. Government regulations

12 March 2025

China·Healthcare·Investments·News·Nvidia·Policy·Technology

DeepSeek AI Ignites a Rush in Chinese Tech Investments: Can It Sustain the Momentum?

The rise of DeepSeek AI is rejuvenating interest in Chinese innovation, reversing declining venture capital trends and spurring investor interest. Investors, driven by FOMO, are flocking to China’s tech scene, leading to renewed confidence and potential recovery from a historic low of

12 March 2025

AI·Artificial intelligence·China·Healthcare·Intel·Investment·News·Policy

China’s AI Resurgence: A DeepSeek-Driven Revolution Captivates Global Investors

DeepSeek’s AI breakthrough has rejuvenated China’s venture capital scene, drawing international interest back to Chinese tech firms. The launch of a rival to OpenAI by DeepSeek has sparked an “avalanche” of investments, exemplified by Insilico Medicine’s $110 million Series E round. Insilico

12 March 2025